Physician profile
Robyn Epley
NPI 1962844316
$2,219.51
in general payments reported to CMS, 2019-2025
13 companies · $54.61 in 2025
The $54.61 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2020: $342 · 2021: $142 · 2022: $176 · 2023: $147 · 2024: $264 · 2025: $54.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,219.88 | 2019-2022 | |
| Alcon Vision LLC | $577.31 | 2019-2025 | Precision 1, Total30, Precision7 |
| Sun Pharmaceutical Industries INC. | $114.36 | 2021 | |
| Horizon Therapeutics Plc | $88.26 | 2023 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $66.85 | 2022 | |
| Rxsight INC | $42.45 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Abbvie INC. | $25.66 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.36 | 2020 | |
| Coopervision INC. | $15.82 | 2023 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $14.62 | 2025 | Xdemvy |
| Tearlab Corp | $13.35 | 2021 | |
| Allergan, INC. | $12.99 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Epley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.